Understanding mechanisms of JAK1 inhibition on synovial fibroblasts using combinatorial approaches of bulk and single cell RNAseq analyses.

IF 3.4 4区 医学 Q2 RHEUMATOLOGY
Yuna Son, Daniel Korenfeld, Abel Suarez-Fueyo, Melanie Ruzek, Jing Wang, Bohdan Harvey
{"title":"Understanding mechanisms of JAK1 inhibition on synovial fibroblasts using combinatorial approaches of bulk and single cell RNAseq analyses.","authors":"Yuna Son, Daniel Korenfeld, Abel Suarez-Fueyo, Melanie Ruzek, Jing Wang, Bohdan Harvey","doi":"10.55563/clinexprheumatol/s705qn","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The aim of these studies was to characterise the molecular effects of a tool JAK1 inhibitor on cultured primary fibroblast-like synoviocytes (FLS) from patients with rheumatoid arthritis (RA) through both total and individual cell analysis.</p><p><strong>Methods: </strong>RA-FLS cultures from 6 (Bulk RNA-seq) or 4 (ScRNA-seq) donors were pre-treated with various concentrations (100 nM and 1μM) of ABT-317 with/without exposure to 25% SEB-conditioned PBMC medium to mimic the RA inflammatory milieu. Cells were subjected to both bulk RNA-seq (36 libraries) and single cell RNA-seq (scRNA-seq; 24 libraries) to identify biological processes impacted by CM and ABT-317 treatments.</p><p><strong>Results: </strong>In our bulk RNA-seq analysis, a total of 2,605 differentially expressed genes (DEGs) were identified between CM-stimulation and unstimulated groups, while 1,122 DEGs were found between ABT-317 1μM and DMSO in CM-stimulated groups using thresholds of log2 (fold change) ≥ |0.58| and FDR ≤ 10%. Both bulk and single cell mRNA analysis of RA-FLS treated with a combination of CM and ABT-317 demonstrated the expected changes in inflammatory pathways such as interferon and IL-6 signalling. However, other non-inflammation associated pathways were also altered by ABT-317. In addition, the single cell analysis highlighted that FLS segregate into distinctive clusters upon combination CM and ABT-317 treatment, suggesting JAK inhibition can drive RA-FLS into multiple heterogenous cell populations. Interestingly, one of the unique RA-FLS clusters that emerged from the CM and ABT-317 treatment showed matrix metalloproteinase-3 (MMP3)high expression as well as several gene signatures that are not found in any other ABT-317 derived clusters.</p><p><strong>Conclusions: </strong>JAK inhibition with ABT-317 is effective at globally inhibiting CM-induced pro- and non-inflammatory pathways in FLS cultures, but also results in several distinct fibroblast populations with unique gene-associated pathways. This study advances the molecular understanding of JAK1 inhibitor effects on fibroblasts that may contribute to clinical efficacy.</p>","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and experimental rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.55563/clinexprheumatol/s705qn","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The aim of these studies was to characterise the molecular effects of a tool JAK1 inhibitor on cultured primary fibroblast-like synoviocytes (FLS) from patients with rheumatoid arthritis (RA) through both total and individual cell analysis.

Methods: RA-FLS cultures from 6 (Bulk RNA-seq) or 4 (ScRNA-seq) donors were pre-treated with various concentrations (100 nM and 1μM) of ABT-317 with/without exposure to 25% SEB-conditioned PBMC medium to mimic the RA inflammatory milieu. Cells were subjected to both bulk RNA-seq (36 libraries) and single cell RNA-seq (scRNA-seq; 24 libraries) to identify biological processes impacted by CM and ABT-317 treatments.

Results: In our bulk RNA-seq analysis, a total of 2,605 differentially expressed genes (DEGs) were identified between CM-stimulation and unstimulated groups, while 1,122 DEGs were found between ABT-317 1μM and DMSO in CM-stimulated groups using thresholds of log2 (fold change) ≥ |0.58| and FDR ≤ 10%. Both bulk and single cell mRNA analysis of RA-FLS treated with a combination of CM and ABT-317 demonstrated the expected changes in inflammatory pathways such as interferon and IL-6 signalling. However, other non-inflammation associated pathways were also altered by ABT-317. In addition, the single cell analysis highlighted that FLS segregate into distinctive clusters upon combination CM and ABT-317 treatment, suggesting JAK inhibition can drive RA-FLS into multiple heterogenous cell populations. Interestingly, one of the unique RA-FLS clusters that emerged from the CM and ABT-317 treatment showed matrix metalloproteinase-3 (MMP3)high expression as well as several gene signatures that are not found in any other ABT-317 derived clusters.

Conclusions: JAK inhibition with ABT-317 is effective at globally inhibiting CM-induced pro- and non-inflammatory pathways in FLS cultures, but also results in several distinct fibroblast populations with unique gene-associated pathways. This study advances the molecular understanding of JAK1 inhibitor effects on fibroblasts that may contribute to clinical efficacy.

利用体细胞和单细胞 RNAseq 分析的组合方法了解 JAK1 对滑膜成纤维细胞的抑制机制。
研究目的这些研究旨在通过总体和单个细胞分析,确定一种工具性 JAK1 抑制剂对类风湿性关节炎(RA)患者培养的原代成纤维细胞样滑膜细胞(FLS)的分子影响:用不同浓度(100 nM 和 1μM)的 ABT-317 预处理来自 6 名(大量 RNA-seq)或 4 名(ScRNA-seq)供体的 RA-FLS 培养物,同时/不暴露于 25% SEB 调节的 PBMC 培养基,以模拟 RA 炎症环境。对细胞进行大量 RNA-seq(36 个文库)和单细胞 RNA-seq(scRNA-seq,24 个文库)分析,以确定 CM 和 ABT-317 处理对生物过程的影响:在大量 RNA-seq 分析中,我们在 CM 刺激组和非刺激组之间共鉴定出 2,605 个差异表达基因 (DEGs),而在 CM 刺激组 ABT-317 1μM 和 DMSO 之间发现了 1,122 个 DEGs,阈值为 log2(折叠变化)≥ |0.58|,FDR ≤ 10%。用 CM 和 ABT-317 联合治疗 RA-FLS 的大量和单细胞 mRNA 分析表明,炎症通路(如干扰素和 IL-6 信号)发生了预期的变化。不过,ABT-317 也改变了其他非炎症相关通路。此外,单细胞分析突出显示,FLS 在 CM 和 ABT-317 联合治疗后会分离成不同的细胞群,这表明 JAK 抑制可将 RA-FLS 驱动成多个异源细胞群。有趣的是,在CM和ABT-317处理后出现的独特RA-FLS集群中,有一个集群显示出基质金属蛋白酶-3(MMP3)的高表达以及多个基因特征,而这些特征在其他ABT-317衍生集群中均未发现:结论:ABT-317抑制JAK能有效抑制FLS培养物中CM诱导的促炎症和非炎症通路,但同时也会产生几个具有独特基因相关通路的不同成纤维细胞群。这项研究加深了人们对 JAK1 抑制剂对成纤维细胞影响的分子认识,这可能有助于提高临床疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.10
自引率
18.90%
发文量
377
审稿时长
3-6 weeks
期刊介绍: Clinical and Experimental Rheumatology is a bi-monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信